Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure...
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The 8-aminoquinoline antimalarials, the only drugs which prevent relapse of vivax and ovale malaria (radical cure), cause dose-dependent oxidant haemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Patients with <30% and <70% of normal G6PD activity are not given standard regimens of primaquine and tafenoquine, respec...
Alternative Titles
Full title
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2039772054
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2039772054
Other Identifiers
ISSN
1935-2735,1935-2727
E-ISSN
1935-2735
DOI
10.1371/journal.pntd.0006440
